Advances in pathogenesis and treatment of vascular endothelial injury-related diseases mediated by mitochondrial abnormality
Boxian Pang(National Center for Nanoscience and Technology), Xing Chang(Chinese Academy of Medical Sciences & Peking Union Medical College), Guangtong Dong(Beijing University of Chinese Medicine), Tieliang Pang(Capital Medical University), Xinyao Sun(Beijing University of Chinese Medicine), Xin Liu(University of Nottingham), Yifeng Nie(National Center for Nanoscience and Technology)
Cited by 125
Related Papers
Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunction
|Angiogenesis|2024|215
Nuclear receptor subfamily 4 group A member 1 promotes myocardial ischemia/reperfusion injury through inducing mitochondrial fission factor-mediated mitochondrial fragmentation and inhibiting FUN14 domain containing 1-depedent mitophagy
|International Journal of Biological Sciences|2024|165
New insights into the role of mitochondrial metabolic dysregulation and immune infiltration in septic cardiomyopathy by integrated bioinformatics analysis and experimental validation
|Cellular & Molecular Biology Letters|2024|148
Targeting mitochondria by lipid-selenium conjugate drug results in malate/fumarate exhaustion and induces mitophagy-mediated necroptosis suppression
|International Journal of Biological Sciences|2024|115
Involvement of mitochondrial dynamics and mitophagy in diabetic endothelial dysfunction and cardiac microvascular injury
|Archives of Toxicology|2023|108